Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1984 1
1985 1
1986 1
1987 3
1988 2
1989 3
1990 3
1991 2
1992 3
1993 2
1994 3
1996 1
1997 3
1998 1
2000 3
2001 1
2002 2
2004 4
2005 1
2006 1
2007 2
2008 1
2010 1
2011 1
2012 2
2013 2
2014 3
2016 2
2017 4
2018 3
2019 3
2021 2
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Malignant hyperthermia, susceptibility to, 5"
Page 1
Malignant hyperthermia.
Gronert GA. Gronert GA. Anesthesiology. 1980 Nov;53(5):395-423. doi: 10.1097/00000542-198011000-00007. Anesthesiology. 1980. PMID: 6999950 Free article. Review.
The best-accepted theory is that MH is due to an inability to control calcium concentrations within the muscle fiber, and may involve a generalized alteration in cellular or subcellular membrane permeability. Episodes are predictably initiated in susceptible people …
The best-accepted theory is that MH is due to an inability to control calcium concentrations within the muscle fiber, and may involve a gene …
Idiopathic hyperCKemia and malignant hyperthermia susceptibility.
Santos JM, Andrade PV, Galleni L, Vainzof M, Sobreira CFR, Schmidt B, Oliveira ASB, Amaral JLG, Silva HCA. Santos JM, et al. Can J Anaesth. 2017 Dec;64(12):1202-1210. doi: 10.1007/s12630-017-0978-x. Epub 2017 Sep 26. Can J Anaesth. 2017. PMID: 28952030 English.
One of the neuromuscular diseases associated with hyperCKemia is malignant hyperthermia (MH). This study investigated the susceptibility to MH in patients with hyperCKemia via in vitro contracture testing (IVCT) and a search of mutations in the RYR1 gene. ... …
One of the neuromuscular diseases associated with hyperCKemia is malignant hyperthermia (MH). This study investigated the s …
Pharmacogenetics and pathophysiology of CACNA1S mutations in malignant hyperthermia.
Beam TA, Loudermilk EF, Kisor DF. Beam TA, et al. Physiol Genomics. 2017 Feb 1;49(2):81-87. doi: 10.1152/physiolgenomics.00126.2016. Epub 2016 Dec 23. Physiol Genomics. 2017. PMID: 28011884 Review.
A review of the pharmacogenetics (PGt) and pathophysiology of calcium voltage-gated channel subunit alpha1 S (CACNA1S) mutations in malignant hyperthermia susceptibility type 5 (MHS5; MIM #60188) is presented. Malignant hyperthermia (MH) …
A review of the pharmacogenetics (PGt) and pathophysiology of calcium voltage-gated channel subunit alpha1 S (CACNA1S) mutations in malig …
Pathophysiology of malignant hyperthermia.
Ording H. Ording H. Ann Fr Anesth Reanim. 1989;8(5):411-6. doi: 10.1016/S0750-7658(89)80007-3. Ann Fr Anesth Reanim. 1989. PMID: 2697155 Review.
Malignant hyperthermia (MH) is a pharmacogenetic disease in man and animals. It primarily involves skeletal muscle tissue, but other tissues might be affected to a lesser degree. Calcium homeostasis in muscle cells is upset in susceptible individuals, …
Malignant hyperthermia (MH) is a pharmacogenetic disease in man and animals. It primarily involves skeletal muscle tiss …
Susceptibility of epithelial tumour cell lines to hyperthermia.
Li ZX, Wang HX, Yang Y, Qi RQ, Li YL, Yu AJ, Gao XH. Li ZX, et al. Eur J Dermatol. 2018 Oct 1;28(5):606-612. doi: 10.1684/ejd.2018.3417. Eur J Dermatol. 2018. PMID: 30530432
BACKGROUND: Human skin or mucosa exposes cells to both an internal and exogeneous thermal environment and the cells survive within a certain range of temperature. Exogeneous hyperthermia has been applied for the treatment of various types of cancers, fungal disease, …
BACKGROUND: Human skin or mucosa exposes cells to both an internal and exogeneous thermal environment and the cells survive within a certain …
Fatigue, depression, and physical activity in patients with malignant hyperthermia: a cross-sectional observational study.
Andrade PMV, Valim LÍM, Santos JMD, Castro I, Amaral JLGD, Silva HCAD. Andrade PMV, et al. Braz J Anesthesiol. 2023 Mar-Apr;73(2):132-137. doi: 10.1016/j.bjane.2021.07.038. Epub 2021 Oct 6. Braz J Anesthesiol. 2023. PMID: 34626754 Free PMC article.
BACKGROUND: Malignant Hyperthermia (MH) is a pharmacogenetic disorder triggered by halogenated anesthesia agents/succinylcholine and characterized by hypermetabolism crisis during anesthesia, but also by day-to-day symptoms, such as exercise intolerance, that may al …
BACKGROUND: Malignant Hyperthermia (MH) is a pharmacogenetic disorder triggered by halogenated anesthesia agents/succinylcholi …
Pre-operative exercise and pyrexia as modifying factors in malignant hyperthermia (MH).
Riazi S, Bersselaar LRVD, Islander G, Heytens L, Snoeck MMJ, Bjorksten A, Gillies R, Dranitsaris G, Hellblom A, Treves S, Kunst G, Voermans NC, Jungbluth H. Riazi S, et al. Neuromuscul Disord. 2022 Aug;32(8):628-634. doi: 10.1016/j.nmd.2022.06.003. Epub 2022 Jun 11. Neuromuscul Disord. 2022. PMID: 35738978 Free article.
Malignant hyperthermia (MH) is a life-threatening reaction triggered by volatile anesthetics and succinylcholine. ...We investigated the role of pre-operative exercise and pyrexia as potential MH modifying factors. We included cases from 5 MH referral centers …
Malignant hyperthermia (MH) is a life-threatening reaction triggered by volatile anesthetics and succinylcholine. ...We invest …
Distinct pathophysiological characteristics in developing muscle from patients susceptible to malignant hyperthermia.
Figueroa L, Kraeva N, Manno C, Ibarra-Moreno CA, Tammineni ER, Riazi S, Rios E. Figueroa L, et al. Br J Anaesth. 2023 Jul;131(1):47-55. doi: 10.1016/j.bja.2023.01.008. Epub 2023 Feb 13. Br J Anaesth. 2023. PMID: 36792386
By measuring sensitivity to halothane of myotubes and extending clinical observations and cell-level studies to a large group of patients, we reach new insights into the pathological mechanism of malignant hyperthermia susceptibility. METHODS: Patients …
By measuring sensitivity to halothane of myotubes and extending clinical observations and cell-level studies to a large group of pati …
Using exome data to identify malignant hyperthermia susceptibility mutations.
Gonsalves SG, Ng D, Johnston JJ, Teer JK, Stenson PD, Cooper DN, Mullikin JC, Biesecker LG; NISC Comparative Sequencing Program. Gonsalves SG, et al. Anesthesiology. 2013 Nov;119(5):1043-53. doi: 10.1097/ALN.0b013e3182a8a8e7. Anesthesiology. 2013. PMID: 24195946 Free PMC article.
BACKGROUND: Malignant hyperthermia susceptibility (MHS) is a life-threatening, inherited disorder of muscle calcium metabolism, triggered by anesthetics and depolarizing muscle relaxants. ...Variants were scored on a six-point pathogenicity scale. Medical his …
BACKGROUND: Malignant hyperthermia susceptibility (MHS) is a life-threatening, inherited disorder of muscle calcium met …
BMI and malignant hyperthermia pathogenic ryanodine receptor type 1 sequence variants in Switzerland: A retrospective cohort analysis.
Gonzalez A, Girard T, Dell-Kuster S, Urwyler A, Bandschapp O. Gonzalez A, et al. Eur J Anaesthesiol. 2021 Jul 1;38(7):751-757. doi: 10.1097/EJA.0000000000001399. Eur J Anaesthesiol. 2021. PMID: 33259453
OUTCOME MEASURES: BMI values were compared amongst malignant hyperthermia susceptible (MHS) and malignant hyperthermia-negative individuals using hierarchical multivariable analyses adjusted for age and sex and considering family clustering. ... …
OUTCOME MEASURES: BMI values were compared amongst malignant hyperthermia susceptible (MHS) and malignant hyp …
70 results